SEC Filings

Filing date	Form	Description	View
03/28/23	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001104659-23-037712.pdf 0001104659-23-037712.rtf 0001104659-23-037712.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
03/17/23	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0001104659-23-033843.pdf 0001104659-23-033843.rtf 0001104659-23-033843.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
03/16/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-005044.pdf 0001415889-23-005044.rtf 0001415889-23-005044.xls
03/13/23	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-031420.pdf 0001104659-23-031420.rtf 0001104659-23-031420.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
03/13/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-004799.pdf 0001415889-23-004799.rtf 0001415889-23-004799.xls
03/08/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-004552.pdf 0001415889-23-004552.rtf 0001415889-23-004552.xls
03/03/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-004271.pdf 0001415889-23-004271.rtf 0001415889-23-004271.xls
03/03/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-004269.pdf 0001415889-23-004269.rtf 0001415889-23-004269.xls
03/03/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-004277.pdf 0001415889-23-004277.rtf 0001415889-23-004277.xls
03/03/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-004273.pdf 0001415889-23-004273.rtf 0001415889-23-004273.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.